Introduction
Familial occurrence of chronic inflammatory bowel disease has been reported in several studies during the past decades. '15 The prevalence reported among first degree relatives seems to be much higher than expected from the prevalence in the background populations. Familial aggregation may be due to shared genes as well as to shared environments-for example common customs, dietary habits, or exposures to viruses, toxins, or chemicals.
In a regional study including about 1 0% of the Danish population we found the population relative risk of ulcerative colitis and Crohn's disease among first degree relatives of patients with either disease to be about 10, which strongly suggests that these disorders have a genetic cause. 6 To explore the mode of inheritance further we performed a complex segregation analysis.7 This allows testing of hypotheses of inheritance of a major dominant, additive, or recessive gene and multifactorial genetic or environmental inheritance.
Patients and methods
The county of Copenhagen has about 500 000 inhabitants, about 1 0% of the total Danish population. The annual incidence of ulcerative colitis and Crohn's disease in this region was estimated for the years 1962 to 1978 and the prevalences on 31 December 1978 were calculated.8 Of the 694 patients with prevalent disease in 1978, 662 were alive on 1 January 1987. These patients served as probands in the present study.
The diagnostic criteria for ulcerative colitis and Crohn's disease in the probands have been described.68 Briefly, the diagnosis of ulcerative colitis was based on the presence of at least three of the following four criteria: a typical history of diarrhoea; stools containing blood and pus, or both, for more than one week or in repeated episodes; a typical sigmoidoscopic appearance, with granulated friable mucosa or ulcerations, or both; histological or cytological signs of inflammation; and radiological or colonoscopic signs of ulcerations with or without spiculation or granulation of the inner surface of the colon proximal to the rectum. The diagnosis of Crohn's disease was based on the presence of at least two of the following four criteria: a history of diarrhoea lasting more than three months; radiological findings of typical stenoses and prestenotic dilatation in the small bowel or segments with a cobblestone appearance in the large bowel; histological findings of transmural lymphocytic infiltration or occurrence of epithelial granulomas with giant cells of Langhans' type, or both; and the occurrence of fistulas or abscesses, or both, in a region of intestinal disease. Before either ulcerative colitis or Crohn's disease was diagnosed infectious and neoplastic diseases had to be ruled out.
In 10 patients who had met the criteria for ulcerative colitis in 1978 the diagnosis was later changed to Crohn's disease; the diagnosis was changed to ulcerative colitis in three patients who had originally had Crohn's disease diagnosed. The diagnoses presented in this study were those made in 1987-that is, the conclusion reached after a median 15 (9-49) years of observation.
We sent a questionnaire requesting complete family history to each patient. Adequate information was obtained from 637 of the 662 patients (96%): 504 patients with ulcerative colitis and 133 patients with Crohn's disease. 6 We telephoned all patients who stated that actual or possible inflammatory bowel disease was present in one or more family members and obtained the names and dates of birth of the affected family members. The diagnosis was confirmed or excluded by applying the criteria mentioned above to the relatives' medical records from hospitals or private physicians. Fifty four probands with ulcerative colitis had 77 relatives with the same disease (46 first degree relatives, 22 second degree, nine third or fourth degree). Two of these 54 probands had two relatives with Crohn's disease, and another five probands had seven relatives with Crohn's disease. Five probands with Crohn's disease had seven relatives with that disease (four first degree, three second degree), and four Crohn's disease probands had six relatives with ulcerative colitis. All first degree relatives of the affected family members were characterised with regard to sex and year of birth (and death). The occurrence of multiple probands in the families has been described. 6 Patients who refused to participate, who did not answer the letters or telephone calls, or who were adopted or unable to give information about bowel disease in their relatives were not included in the segregation analysis, nor were children younger than 8 years of age.
STATISTICAL ANALYSIS
The complex segregation analysis is based on the distribution of the disease in nuclear families (parents and their offspring). Each pedigree ascertained on the basis of the probands can contain one or more nuclear families. The Table III gives the results of the complex segregation analyses for ulcerative colitis. The sporadic modelthat is, the model not including any family resemblance (H=q=0)-gave a poor fit compared with the multifactorial model (H>0) (X2=6O52-(-3081)= 91-33; p<0001). There was no evidence of an intergenerational difference (Z=0 67) for multifactorial heritability (x2=-30X81-(-3167)=086). Among the three models that incorporated a major locus (q > 0) the recessive model (d=0) did not explain the observed segregation pattem as well as the dominant model (X2=2 42 for the recessive model, x2= 5 121, p<0-005 BMJ VOLUME 306 2 JANUARY 1993 for the dominant model). The additive model (d=0-5) yielded an equivalent likelihood to that of the dominant model (d= 1) with corresponding estimated parameters (same q, and t of the dominant model equals txd of the additive model). This was due to the low frequency of the susceptibility allele (43x 10-5) and the resulting low probability that any of the affected patients were homozygous. In fact, no families had both parents affected (table I) . There was no evidence for an additional transmissible multifactorial component since H always went to zero when iterating all parameters. Table IV gives the characteristics of the major dominant locus for ulcerative colitis by liability class. The penetrance (probability of having the disease for given genotype expressed as P (diseaselgenotype)) of the abnormal allele A' was almost the same for the liability classes above class 1, being 0-26 in the heterozygote or homozygote for the highest incidence groups. This means that by age 30-59 a heterozygote or homozygote has a 26% risk of having ulcerative colitis.
Conversely, the frequency with which disease can be attributed to the abnormal allele (P(genotypeldisease)) decreased with age. Before the age of 20, 32% of the patients with ulcerative colitis were heterozygous or homozygous carriers of the major gene. In the higher liability classes the probability of an affected individual being heterozygous or homozygous for the major allele was about 0 10. This means that about 90% of the adult patients with ulcerative colitis have a normal genotype.
CROHN 'S DISEASE Table V shows the results of the segregation analysis for Crohn's disease. The sporadic model was definitely ruled out when compared with the multifactorial model (xI= 17X05). The multifactorial model tended to fit better when an intergenerational difference was included (Z estimated at 0 05, corresponding to a much lower heritability among parents (ZH) than among offspring (H)), but it was not significantly better (X2=3-28, p=0-075). The model including a recessive major locus gave a better fit than the model including an additive or a dominant locus, but the fit was not significantly better than for the multifactorial model with or without a generational difference.
The difficulty in distinguishing between hypotheses was not surprising since only 209 families with Crohn's disease were available for analysis. If the recessive major locus model is accepted the gene frequency would be 59x10-. Under the major gene models, H always went to zero so no additional transmissible multifactorial component was evident. Table VI shows the penetrance of the major gene locus in affected subjects with various genotypes by liability class derived from the model including a major recessive gene. The overall probability for a patient with Crohn's disease being homozygous for the major locus for Crohn's disease was 0 07. Before age 20, 28% of the patients were homozygous. Penetrance was almost complete for the recessive homozygote in all liability classes.
Discussion
In a previous paper we estimated that the sex and age standardised population relative risk for ulcerative colitis and Crohn's disease was about 10 among first degree relatives of probands with ulcerative colitis and Crohn's disease. 6 The size of the relative risk strongly suggests a genetic contribution." Assuming genetic influences, the mode of inheritance can be investigated by segregation analysis of pedigree data.
The results of our complex segregation analysis suggest that a major dominant gene is present in about 10% of patients with ulcerative colitis. The penetrance of the dominant gene in adults was estimated at 0-26 hence the risk of disease in an adult offspring of a patient with ulcerative colitis induced by this gene may be 13%.
Although the result was not significant, segregation analysis of the families with Crohn's disease suggested that a major recessive gene is present in about 7%,/0 of patients with this disease. Since the penetrance of this recessive susceptibility gene for Crohn's disease in the homozygote was almost complete, the risk of disease in a child with one parent with Crohn's disease induced by this gene and one unaffected parent is about 30 x 10-4-namely, half the estimated gene frequency in the background population.
Thus a considerable number of cases of both ulcerative colitis and Crohn's disease are sporadic or non-genetic. This is, however, compatible with a population relative risk of 10 for family members BMJ VOLUME 306 because the population relative risk reflects the familial occurrence relative to the population occurrence.
RESULTS OF OTHER STUDIES
Only a few studies have included segregation analysis of family data on chronic inflammatory bowel disease. '2-'4 Comparison of these studies is difficult because of different patient populations. Selection bias is specially important in family studies of diseases in which only a minority of the cases have a genetic origin. We studied an unselected, regionally defined, relatively large group of thoroughly characterised patients over at least nine years. During these years the diagnosis had been corrected in 13 patients. We did not obtain data on the families of patients with inflammatory bowel disease who died between 1978 and 1987. We believe that this was valid because the mortality rate of patients with inflammatory bowel disease did not differ from that expected in the background population; most patients died of common, age related diseases rather than inflammatory bowel disease'516; and no correlation has been found between severity of disease in probands and familial occurrence in other populations'7 or in ours (unpublished data from our previous study6). Among In a German study designed more like ours except for patients being included from a referral centre, Kiister et al also found evidence for a major recessive gene for Crohn's disease.'4 The proportion of cases explained by presence of the gene was high if the disease had early onset; overall about 30% of cases were due to homozygosity for the susceptibility gene. This is a much higher proportion than we found.
The results of a Swedish study of twins also supported the role of a recessive gene. Eight of 18 monozygotic and one of 26 dizygotic twin pairs were concordant for Crohn's disease.
CONCLUSIONS
To summarise, although the model including a major recessive gene for Crohn's disease did not differ significantly from that for the multifactorial model in our patient population, we find it reasonable to believe in this model. The model gave the best fit for our data (table V) and it is the most plausible model: although the incidence of Crohn's disease has increased9 and although the disease may be underdiagnosed in older people, we believe it unlikely that the intergenerational difference in heritability should be as big as that given in the multifactorial model with generational difference (table V) . Finally, the two other studies in which complex segregation analysis of family data on Crohn's disease was performed also found evidence for the recessive model.
The segregation analysis we used does not enable us to determine the genetic relation between ulcerative colitis and Crohn's disease since disease in relatives has to be defined in the same way as for probands. However, there seems to be a connection. As previously described6 we found the sex and age standardised population relative risk of Crohn's disease among first degree relatives of patients with ulcerative colitis to be 1 72 (95% confidence interval 0-36 to 5 04) and that of ulcerative colitis among first degree relatives of Crohn's disease patients to be 3-85 (1-25 to 8 98) . In the Swedish series of 1048 patients with Crohn's disease 88 (8/4%) had one or more relatives with Crohn's disease, 10 (1%) had relatives with both Crohn's disease and ulcerative colitis, and another 42 (4%) patients had a family history of ulcerative colitis only.5 Among 963 patients with ulcerative colitis 65 (6.7%) had relatives with ulcerative colitis and 11 (1-1%) had relatives with Crohn's disease.4 This co-occurrence of the diseases within families may indicate that more genes, some of which are shared, have a role in the aetiology, and some factors in the shared environment may be of significance for the expression of the diseases. Further studies are needed to elucidate this.
In conclusion, our results suggest that in 10% of patients with ulcerative colitis a dominant major gene is of aetiological importance for the development of the disease, and that about 7% of patients with Crohn's disease are homozygous for a recessive susceptibility gene. The next step may be genetic linkage studies to determine the chromosomal location of the relevant genes.
Appendix
Complex segregation analysis was performed with the computer program POINTER.7 Nuclear families were distinguished according to whether or not they were ascertained through a pointer, which is defined as an affected patient who leads to the ascertainment of a nuclear family but who is not a member of this family.
There were 375 and 80 nuclear families ascertained through a parent affected by ulcerative colitis or Crohn's disease, respectively, which provide complete selection of the possible phenotypes among the offspring of this matching type (table   I ). The remaining families were ascertained through children or other relatives, resulting in incomplete selection of the possible offspring phenotypes. Incomplete selection is corrected for in the analysis by taking into account the ascertainment probability (H1) which is defined as the probability that an affected individual is a proband. It may be estimated from the proportion of probands among affected siblings of each proband (HI=X a(a-l)/X: a(r-1), where a is the number of independently ascertained probands and r the total number of affected siblings within the sibships). HI was estimated at 0-26 for ulcerative colitis families. For Crohn's disease, there was only one proband in each nuclear family, corresponding to a H1 of 0, but for the purpose of the analysis it was set to 0 001.
All the parameters of the model were estimated by maximising the overall likelihood. To test the hypotheses, the relevant parameters were held constant while estimating the remaining parameters. accompanied by an accelerated rise in blood pressure, then the values would be set on a higher than expected plane when tracking of blood pressure becomes established after 6 months of age. 9 10 We examined the timing of initiation of high blood pressure and the occurrence of amplification by bringing together data from four studies of children and adults in Britain.
Methods
We used data from the following studies. In two of them (Famborough and Hertfordshire) weight at 1 year of age was recorded in addition to birth weight.
CHILDREN
Farnborough-The Brompton study of blood pressure was based on 1895 consecutive term ( >38 completed weeks of pregnancy) births at Farnborough Hospital, Kent, from 1975 to 1977. The infants were followed up at 4 days, 6 weeks, 6 months, 1 year, and yearly thereafter to the age of 10 years; at each age systolic pressure and weight were measured by a standardised procedure. A 4 cm cuff was used at ages up to 6 months, an 8 cm cuff from 6 months to 8 years, and a 12 cm cuffon some children aged 5-8 years and all children from 8-10 years. Details of the methods and follow up rates have been published.9 We excluded two children born at more than 42 completed weeks of pregnancy.
